The company's top-line trajectory has deteriorated significantly, evidenced by a 35.7% revenue decline and an operating margin of -96.4% in 2025Q4.
| Sales/Revenue | 18.23M | 29.77M | 34.21M | 28.85M | 23.56M | 8.91M | 18.73M |
| Revenue Growth % | -38.77% | -12.99% | 18.58% | 22.47% | 164.35% | -52.43% | - |
| Cost of Goods Sold | 10.67M | 18.52M | 22.83M | 2.76M | 2.34M | 4.98M | 11.74M |
| COGS % of Revenue | 58.53% | 62.22% | 66.72% | 9.57% | 9.91% | 55.92% | 62.66% |
| Gross Profit | 7.56M | 11.25M | 11.38M | 1.52M | 1.32M | 3.93M | 6.99M |
| Gross Margin % | 41.47% | 37.78% | 33.28% | 5.28% | 5.59% | 44.08% | 37.34% |
| Gross Profit Growth % | -32.79% | -1.22% | 647.7% | 15.61% | -66.47% | -43.84% | - |
| Operating Expenses | 19.21M | 9.25M | 2.77M | 3.9M | 848.53K | 5.56M | 3.55M |
| OpEx % of Revenue | 105.4% | 31.07% | 8.11% | 13.52% | 3.6% | 62.42% | 18.96% |
| Selling, General & Admin | 4.47M | 2.73M | 2.78M | 3.32M | 2.58M | 2.69M | 3.85M |
| SG&A % of Revenue | 24.51% | 9.16% | 8.13% | 11.49% | 10.94% | 30.24% | 20.54% |
| Research & Development | 47.6K | 61.79K | 80.95K | 112.67K | 136.69K | 120.47K | 153.6K |
| R&D % of Revenue | 0.26% | 0.21% | 0.24% | 0.39% | 0.58% | 1.35% | 0.82% |
| Other Operating Expenses | 14.69M | 6.46M | -88.22K | 471.45K | -1.87M | 2.75M | -450.22K |
| Operating Income | -11.65M | 2M | 8.61M | 6.35M | 7.65M | -1.64M | 2.99M |
| Operating Margin % | -63.93% | 6.71% | 25.17% | 22.02% | 32.46% | -18.41% | 15.97% |
| Operating Income Growth % | -683.12% | -76.8% | 35.53% | -16.9% | 566.04% | -154.83% | - |
| EBITDA | -11.41M | 2.34M | 8.95M | 6.43M | 7.69M | -1.22M | 3.46M |
| EBITDA Margin % | -62.61% | 7.87% | 26.17% | 22.27% | 32.65% | -13.7% | 18.47% |
| EBITDA Growth % | -587.05% | -73.84% | 39.35% | -16.45% | 730.11% | -135.28% | - |
| D&A (Non-Cash Add-back) | 240.73K | 344.69K | 342.69K | 71.92K | 45.46K | 419.97K | 468.17K |
| EBIT | -11.54M | 2.01M | 8.61M | 959.42K | 7.65M | -1.54M | 3.44M |
| Net Interest Income | -91.34K | -136.29K | -90.62K | -51.22K | 20.85K | -123.24K | -194.21K |
| Interest Income | 105 | 471 | 15.51K | 13.44K | 89.51K | 1.04K | 2.25K |
| Interest Expense | 91.45K | 136.76K | 106.13K | 64.66K | 68.66K | 124.28K | 196.46K |
| Other Income/Expense | 19.3K | -129.78K | -183.56K | 41.81K | 140.27K | -20.33K | 256.02K |
| Pretax Income | -11.63M | 1.87M | 8.43M | 6.4M | 7.79M | -1.66M | 3.25M |
| Pretax Margin % | -63.82% | 6.28% | 24.64% | 22.17% | 33.05% | -18.64% | 17.34% |
| Income Tax | -1.27M | 462.04K | 1.4M | 1.15M | 1.21M | -132.64K | 751.9K |
| Effective Tax Rate % | 10.88% | 24.73% | 16.66% | 18.03% | 15.51% | 7.99% | 23.15% |
| Net Income | -10.2M | 1.45M | 7.42M | 5.78M | 1.05M | -1.48M | 2.86M |
| Net Margin % | -55.95% | 4.88% | 21.68% | 20.04% | 4.46% | -16.6% | 15.26% |
| Net Income Growth % | -801.71% | -80.41% | 28.29% | 450.35% | 171.03% | -151.74% | - |
| Net Income (Continuing) | -10.37M | 1.41M | 7.02M | 5.24M | 6.58M | -1.53M | 2.5M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 3.89K | 154.28K | 25.89K | 80K | 175.75K | 1.24M | 1.22M |
| EPS (Diluted) | -21.00 | 3.50 | 17.25 | 13.50 | 2.46 | -3.25 | 6.50 |
| EPS Growth % | -700% | -79.71% | 27.78% | 449.9% | 175.54% | -150% | - |
| EPS (Basic) | -21.00 | 3.50 | 17.25 | 13.50 | 2.46 | -3.25 | 6.75 |
| Diluted Shares Outstanding | 485.67K | 412.82K | 428K | 428K | 428K | 448K | 448K |
| Basic Shares Outstanding | 485.67K | 412.82K | 428K | 428K | 428K | 448K | 428K |
| Dividend Payout Ratio | - | - | - | - | - | - | - |
Acute liquidity and insolvency
As reported in recent financial filings, CDTG experienced a severe 35.7% year-over-year revenue decline in 2025Q4, reflecting a broader inability to sustain project-based growth amidst a challenging municipal spending environment that appears to have fundamentally impaired the company's top-line trajectory and market relevance in rural sanitation.
The consistent volatility in revenue suggests that the company's reliance on sporadic, project-based municipal contracts lacks the necessary recurring revenue base to provide stability. This sharp contraction implies that the firm is struggling to secure new project wins, which may be exacerbated by broader economic pressures on local government budgets in its primary operating regions.
Based on the latest income statement data, CDTG's operating margin plummeted to -96.4% in 2025Q4, demonstrating that the company's fixed cost structure is entirely misaligned with its current revenue scale, as SG&A expenses continue to outpace gross profit generation by a significant margin.
The inability to scale operating income alongside gross profit indicates that the company's corporate infrastructure remains bloated relative to its diminished project pipeline. Investors should monitor whether management can implement meaningful cost-cutting measures, as the current operating loss trajectory appears unsustainable without a rapid and substantial recovery in project volume.
According to the company's recent income statements, SG&A expenses reached $2.1 million in 2025Q4, which significantly exceeded the $650.9K in gross profit, highlighting a critical lack of expense discipline that has pushed the firm into deep operating losses during this period of revenue decline.
The high fixed-cost nature of the business model, combined with a sharp drop in revenue, has created a negative feedback loop where the company cannot cover its basic operating expenses. This cost structure warrants further investigation into whether the firm possesses the flexibility to right-size its operations or if it is locked into high-overhead commitments.
As indicated by the reported cash balance of only $9,542 against substantial operating losses, CDTG faces an extreme liquidity risk that suggests the company may be unable to sustain its current operations without immediate external capital, a reality that short-sellers would likely highlight as a primary insolvency risk.
The massive disconnect between the company's reported revenue and its negligible cash reserves suggests that the firm is facing severe collection issues or has already exhausted its working capital. This precarious financial position implies that the company's ability to continue as a going concern is highly questionable, regardless of any potential technological advantages in its modular treatment systems.
Quick answers to the most common questions about buying CDTG stock.
For fiscal year 2025, CDT Environmental Technology Investment Holdings Limited ordinary shares (CDTG) reported total revenue of $18.2M. This represents a 2.7% decline compared to $18.7M in 2019.
CDT Environmental Technology Investment Holdings Limited ordinary shares (CDTG) reported a net loss of $10.2M for the fiscal year ending 2025.
CDT Environmental Technology Investment Holdings Limited ordinary shares (CDTG) reported an operating income of $-11.7M, resulting in an operating profit margin of -63.9%. This margin reflects the operational efficiency of the business before interest and taxes.
CDT Environmental Technology Investment Holdings Limited ordinary shares (CDTG) generated $7.6M in gross profit for the year, representing a gross profit margin of 41.5%. This demonstrates the company's core pricing power and production efficiency.